Renovaro Inc

詳細情報 Renovaro Inc 企業名

Renovaro Inc. specializes in cancer diagnostics and therapeutics powered by artificial intelligence (AI). The Company operates through two subsidiaries: Renovaro Biosciences, Inc. (Renovaro Biosciences) and Renovaro Cube. Renovaro Biosciences is a biotechnology company intending to develop advanced allogeneic cell and gene therapies to promote stronger immune system responses potentially for long-term or life-long cancer remission in some of the deadliest cancers, and potentially to treat or cure serious infectious diseases such as Human Immunodeficiency Virus (HIV) infections. Renovaro Cube is an AI-driven healthcare technology company focusing on the earliest possible detection of cancer and its recurrence. Renovaro Cube has developed an AI platform that analyzes genetics using Explainable AI to provide earlier and more accurate cancer diagnosis. This platform uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients.

企業情報

企業コードRENB

会社名Renovaro Inc

上場日Nov 18, 2014

最高経営責任者「CEO」Mr. David Weinstein

従業員数25

証券種類Ordinary Share

決算期末Nov 18

本社所在地2080 Century Park East,

都市LOS ANGELES

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号90067

電話番号14539179840

ウェブサイトhttps://renovarobio.com/

企業コードRENB

上場日Nov 18, 2014

最高経営責任者「CEO」Mr. David Weinstein

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Maurice Van Tilburg

Independent Chairman of the Board

--

Mr. Chris Tyson

Executive Vice President

--

Mr. David Weinstein

Chief Executive Officer, Director

--

Mr. Nathen Fuentes, CPA

Chief Financial Officer

--

Mr. Douglas W. Calder

Independent Director

--

Mr. Mark Anthony Collins, Ph.D.

Independent Director

--

Mr. James A. Mcnulty, CPA

Independent Director

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Maurice Van Tilburg

Independent Chairman of the Board

--

Mr. Chris Tyson

Executive Vice President

--

Mr. David Weinstein

Chief Executive Officer, Director

--

Mr. Nathen Fuentes, CPA

Chief Financial Officer

--

Mr. Douglas W. Calder

Independent Director

--

Mr. Mark Anthony Collins, Ph.D.

Independent Director

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Sat, Aug 2

株主統計

種類

株主統計

比率

PasecoApS

11.69%

RS Group ApS

7.29%

Gumrukcu (Serhat)

5.42%

BlackRock Institutional Trust Company, N.A.

2.95%

The Vanguard Group, Inc.

2.45%

Other

70.20%

株主統計

比率

PasecoApS

11.69%

RS Group ApS

7.29%

Gumrukcu (Serhat)

5.42%

BlackRock Institutional Trust Company, N.A.

2.95%

The Vanguard Group, Inc.

2.45%

Other

70.20%

種類

株主統計

比率

Corporation

36.84%

Individual Investor

10.44%

Investment Advisor

8.61%

Investment Advisor/Hedge Fund

3.55%

Research Firm

0.41%

Hedge Fund

0.13%

Bank and Trust

0.07%

Pension Fund

0.04%

Other

39.92%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

157

103.42M

47.15%

+42.61M

2025Q1

161

103.48M

60.94%

+42.30M

2024Q4

155

103.71M

63.86%

+49.62M

2024Q3

149

51.49M

35.21%

-1.80M

2024Q2

151

51.88M

36.43%

+6.39M

2024Q1

154

44.98M

32.23%

+3.81M

2023Q4

151

44.01M

67.51%

+217.77K

2023Q3

146

41.12M

71.08%

+1.11M

2023Q2

147

41.48M

71.99%

+3.87M

2023Q1

143

36.45M

65.90%

-482.82K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

PasecoApS

12.62M

7.33%

+8.16M

+182.78%

Oct 17, 2024

RS Group ApS

13.60M

7.9%

+468.70K

+3.57%

Oct 17, 2024

Gumrukcu (Serhat)

12.53M

7.28%

--

Apr 10, 2025

BlackRock Institutional Trust Company, N.A.

6.81M

3.96%

+847.01K

+14.20%

Mar 31, 2025

The Vanguard Group, Inc.

5.66M

3.29%

-58.46K

-1.02%

Mar 31, 2025

William (Anderson Wittekind)

4.77M

2.77%

--

Apr 10, 2025

Geode Capital Management, L.L.C.

2.37M

1.38%

+35.02K

+1.50%

Mar 31, 2025

State Street Global Advisors (US)

2.00M

1.16%

-61.67K

-2.99%

Mar 31, 2025

Weinstein (David Hershel)

250.00K

0.15%

+250.00K

--

Oct 17, 2024

Weird Science LLC

840.32K

0.49%

--

Apr 10, 2025

詳細を見る

0.257USD

Renovaro Inc

0.257

概要

企業名

金融